Novel Therapeutics in Alzheimer's Disease

por Sabbagh, Marwan, Porsteinsson, Anton P., Nair, Anil, Adem, Abdu
Publicado 2012

Temporospatial components of brain ERPs as biomarkers for Alzheimer's disease

por Chapman, Robert M., Gardner, Margaret N., Klorman, Rafael, Mapstone, Mark, Porsteinsson, Anton P., Antonsdottir, Inga M., Kamalyan, Lily
Publicado 2018

APOE ε4/ε4 homozygotes with early Alzheimer's disease show accelerated hippocampal atrophy and cortical thinning that correlates with cognitive decline

por Abushakra, Susan, Porsteinsson, Anton P., Sabbagh, Marwan, Bracoud, Luc, Schaerer, Joel, Power, Aidan, Hey, John A., Scott, David, Suhy, Joyce, Tolar, Martin
Publicado 2020

Efficacy and mechanisms of combined aerobic exercise and cognitive training in mild cognitive impairment: study protocol of the ACT trial

por Yu, Fang, Lin, Feng Vankee, Salisbury, Dereck L., Shah, Krupa N., Chow, Lisa, Vock, David, Nelson, Nathaniel W., Porsteinsson, Anton P., Jack, Clifford
Publicado 2018

A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer’s disease patients with agitation

por Akil, Ayman, Bies, Robert R., Pollock, Bruce G., Avramopoulos, Dimitrios, Devanand, D. P., Mintzer, Jacobo E., Porsteinsson, Anton P., Schneider, Lon S., Weintraub, Daniel, Yesavage, Jerome, Shade, David M., Lyketsos, Constantine G.
Publicado 2015

Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study

por Clark, Emily D., Perin, Jamie, Herrmann, Nathan, Brawman‐Mintzer, Olga, Lanctôt, Krista L., Lerner, Alan J., Mintzer, Jacobo, Padala, Prasad R., Rosenberg, Paul B., Sami, Susie, Shade, David M., van Dyck, Christopher H., Porsteinsson, Anton P.
Publicado 2023

Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition

por Cummings, Jeffrey, Mintzer, Jacobo, Brodaty, Henry, Sano, Mary, Banerjee, Sube, Devanand, D.P., Gauthier, Serge, Howard, Robert, Lanctôt, Krista, Lyketsos, Constantine G., Peskind, Elaine, Porsteinsson, Anton P., Reich, Edgardo, Sampaio, Cristina, Steffens, David, Wortmann, Marc, Zhong, Kate
Publicado 2015

Neurobiologic Rationale for Treatment of Apathy in Alzheimer’s Disease With Methylphenidate

por van Dyck, Christopher H., Arnsten, Amy F.T., Padala, Prasad R., Brawman-Mintzer, Olga, Lerner, Alan J., Porsteinsson, Anton P., Scherer, Roberta W., Levey, Allan I., Herrmann, Nathan, Jamil, Nimra, Mintzer, Jacobo E., Lanctôt, Krista L., Rosenberg, Paul B.
Publicado 2020

Brain amyloid burden, sleep, and 24-hour rest/activity rhythms: screening findings from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s and Longitudinal Evaluation of Amyloi...

por Spira, Adam P, Zipunnikov, Vadim, Raman, Rema, Choi, Jiyoon, Di, Junrui, Bai, Jiawei, Carlsson, Cynthia M, Mintzer, Jacobo E, Marshall, Gad A, Porsteinsson, Anton P, Yaari, Roy, Wanigatunga, Sarah K, Kim, John, Wu, Mark N, Aisen, Paul S, Sperling, Reisa A, Rosenberg, Paul B
Publicado 2021

Changes in QTc Interval in the Citalopram for Agitation in Alzheimer's Disease (CitAD) Randomized Trial

por Drye, Lea T., Spragg, David, Devanand, D. P., Frangakis, Constantine, Marano, Christopher, Meinert, Curtis L., Mintzer, Jacobo E., Munro, Cynthia A., Pelton, Gregory, Pollock, Bruce G., Porsteinsson, Anton P., Rabins, Peter V., Rosenberg, Paul B., Schneider, Lon S., Shade, David M., Weintraub, Daniel, Yesavage, Jerome, Lyketsos, Constantine G.
Publicado 2014